Cargando…
Lipid levels, insulin resistance and cardiovascular risk over 96 weeks of antiretroviral therapy: a randomised controlled trial comparing low-dose stavudine and tenofovir
BACKGROUND: HIV infection and antiretroviral treatment are associated with changes in lipid levels, insulin resistance and risk of cardiovascular disease (CVD). We investigated these changes in the first 96 weeks of treatment with low-dose stavudine or tenofovir regimens. METHODS: This is a secondar...
Autores principales: | Vos, Alinda G., Chersich, Matthew F., Klipstein-Grobusch, Kerstin, Zuithoff, Peter, Moorhouse, Michelle A., Lalla-Edward, Samanta T., Kambugu, Andrew, Kumarasamy, N., Grobbee, Diederick E., Barth, Roos E., Venter, Willem D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295103/ https://www.ncbi.nlm.nih.gov/pubmed/30547820 http://dx.doi.org/10.1186/s12977-018-0460-z |
Ejemplares similares
-
Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low-Dose Stavudine Over 96 Weeks: A Multicountry Randomized, Noninferiority Trial
por: Venter, Willem Daniel Francois, et al.
Publicado: (2019) -
Cardiovascular disease risk in an urban African population: a cross-sectional analysis on the role of HIV and antiretroviral treatment
por: Vos, Alinda G., et al.
Publicado: (2019) -
The influence of HIV infection and antiretroviral treatment on pulmonary function in individuals in an urban setting in sub-Saharan Africa
por: van den Berg, Oda E., et al.
Publicado: (2021) -
Corrigendum: The influence of HIV infection and antiretroviral treatment on pulmonary function in individuals in an urban setting in sub-Saharan Africa
por: van den Berg, Oda E., et al.
Publicado: (2022) -
Pro-Inflammatory Markers in Relation to Cardiovascular Disease in HIV Infection. A Systematic Review
por: Vos, Alinda G., et al.
Publicado: (2016)